Systemic infusion of autologous adipose tissue-derived mesenchymal stem cells in peritoneal dialysis patients: feasibility and safety

Sudabeh, Alatab; Soroosh, Shekarchian; Iraj, Najafi; Reza, Moghadasali; Naser, Ahmadbeigi; Mohammad, Pourmand; Tina, Bolurieh; Neda, Jaroughi; Gholamreza, Pourmand; Nasser, Aghdami

Sudabeh, Alatab; Soroosh, Shekarchian; Iraj, Najafi; Reza, Moghadasali; Naser, Ahmadbeigi; Mohammad, Pourmand; Tina, Bolurieh; Neda, Jaroughi; Gholamreza, Pourmand; Nasser, Aghdami.

Cell Journal [Yakhteh]. 2019; 20 (4): 483-495

in English | IMEMR | ID: emr-199617

ABSTRACT

ABSTRACT

Objective:

Using mesenchymal stem cells [MSCs] is regarded as a new therapeutic approach for improving fibrotic diseases.The aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs [AD-MSCs] in peritoneal dialysis [PD] patients with expected peritoneal fibrosis

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Controlled clinical trial Language: English Journal: Cell J. [Yakhteh] Year: 2019

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Controlled clinical trial Language: English Journal: Cell J. [Yakhteh] Year: 2019